Dual biologic therapy offers possible option for refractory IBD
Simultaneous use of biologic agents in combination or with Xeljanz may be a viable treatment option for highly selected, refractory patients with inflammatory bowel disease, according to study results. Robert Battat, MD, from...
Read More